High materiality8/10
VRTX insider sale by Tatsis Ourania
Why it may matterVerify against the original reporting
insider sale implies potential downside pressure for VRTX.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Tatsis Ourania reported a sale in Vertex Pharmaceuticals (VRTX) worth about $787,485.
- Insider sale: VRTX by Tatsis Ourania
Key facts
- 01
Insider: Tatsis Ourania
- 02
Role: officer: EVP, Chief Reg. & Quality Off.
- 03
Transaction: S-Sale
- 04
Shares: 1,500
- 05
Price: $524.99
- 06
Value: $787,485
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.